A phase III randomized controlled trial of radiation dose optimization in non‐Hodgkin lymphoma‐diffuse large B‐cell lymphoma (DOBL study): Study protocol and design

BACKGROUND: Radiation therapy for diffuse large B‐cell lymphoma (DLBCL) has shown improvement in progression free survival. There is uncertainty about the optimal radiation dose, with heterogeneous doses being used, ranging from 30 to 55 Gy. This trial tests the efficacy of using reduced radiation d...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Rep (Hoboken)
Main Authors: Goda, Jayant S., Lewis, Shirly C., Laskar, Siddartha, Kannan, Sadhna, Khanna, Nehal, Jain, Hasmukh, Bagal, Bhausaheb, Epari, Sridhar
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2019
Teme:
Registered Report Stage 1: Study Design
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7941552/
https://ncbi.nlm.nih.gov/pubmed/32935480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cnr2.1161
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki